Cyril Šálek

Calreticulin exposure by malignant blasts correlates with robust anticancer immunity and improved clinical outcome in AML patients

Jitka Fučíková, Iva Truxová, Michal Hensler et al. · Blood · 2016 · 130 citations · Full text

Evaluation of clinical relevance of examining K-ras, p16 and p53 mutations along with allelic losses at 9p and 18q in EUS-guided fine needle aspiration samples of patients with chronic pancreatitis and pancreatic cancer

Cyril Šálek · World Journal of Gastroenterology · 2007 · 98 citations · Full text

High PD-L1 Expression Predicts for Worse Outcome of Leukemia Patients with Concomitant NPM1 and FLT3 Mutations

Barbora Brodská, Petra Otevřelová, Cyril Šálek et al. · International Journal of Molecular Sciences · 2019 · 59 citations · Full text

Rapid identification of <i><scp>BCR</scp>/<scp>ABL</scp>1</i>‐like acute lymphoblastic leukaemia patients using a predictive statistical model based on quantitative real time‐polymerase chain reaction: clinical, prognostic and therapeutic implications

Sabina Chiaretti, Monica Messina, Sara Grammatico et al. · British Journal of Haematology · 2018 · 57 citations · Full text

TIM-3 levels correlate with enhanced NK cell cytotoxicity and improved clinical outcome in AML patients

Jana Raková, Iva Truxová, Peter Holíček et al. · OncoImmunology · 2021 · 52 citations · Full text